# A Study to Assess the Effects on the Single-Dose Drug Levels of Mavacamten in Healthy Participants

> **NCT05658146** · PHASE1 · COMPLETED · sponsor: **Bristol-Myers Squibb** · enrollment: 95 (actual)

## Conditions studied

- Healthy Participants

## Interventions

- **DRUG:** Mavacamten Capsule 1
- **DRUG:** Mavacamten Capsule 2
- **DRUG:** Mavacamten Capsule 3

## Key facts

- **NCT ID:** NCT05658146
- **Lead sponsor:** Bristol-Myers Squibb
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-01-06
- **Primary completion:** 2023-07-05
- **Final completion:** 2023-07-05
- **Target enrollment:** 95 (ACTUAL)
- **Last updated:** 2023-10-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05658146

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05658146, "A Study to Assess the Effects on the Single-Dose Drug Levels of Mavacamten in Healthy Participants". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05658146. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*